CGC vs. TLRY, CRON, USNA, MNMD, BTMD, ACB, CDXC, MDWD, FTLF, and BGXX
Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), biote (BTMD), Aurora Cannabis (ACB), ChromaDex (CDXC), MediWound (MDWD), FitLife Brands (FTLF), and Bright Green (BGXX). These companies are all part of the "medicinals & botanicals" industry.
Tilray (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk, institutional ownership and community ranking.
9.4% of Tilray shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.7% of Tilray shares are owned by insiders. Comparatively, 0.4% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Tilray has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.
Tilray received 427 more outperform votes than Canopy Growth when rated by MarketBeat users. Likewise, 59.28% of users gave Tilray an outperform vote while only 19.80% of users gave Canopy Growth an outperform vote.
In the previous week, Tilray had 1 more articles in the media than Canopy Growth. MarketBeat recorded 12 mentions for Tilray and 11 mentions for Canopy Growth. Tilray's average media sentiment score of 1.23 beat Canopy Growth's score of 0.39 indicating that Canopy Growth is being referred to more favorably in the news media.
Tilray has a net margin of -43.98% compared to Tilray's net margin of -185.77%. Canopy Growth's return on equity of -2.68% beat Tilray's return on equity.
Canopy Growth has higher revenue and earnings than Tilray. Tilray is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.
Tilray presently has a consensus price target of $2.71, indicating a potential upside of 53.01%. Canopy Growth has a consensus price target of $4.87, indicating a potential downside of 30.77%. Given Canopy Growth's stronger consensus rating and higher possible upside, analysts clearly believe Tilray is more favorable than Canopy Growth.
Summary
Tilray beats Canopy Growth on 14 of the 18 factors compared between the two stocks.
Get Canopy Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Canopy Growth Competitors List
Related Companies and Tools
